吃奶呻吟打开双腿做受动态图 -亚洲色偷偷色噜噜狠狠99网-日韩精品极品视频在线观看免费-来一水AV@lysav

掃碼關(guān)注公眾號(hào)           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
无码熟熟妇丰满人妻啪啪,欧美激情综合色综合啪啪五月,后入内射无码人妻一区
首頁 > 產(chǎn)品中心 > 一抗 > 產(chǎn)品信息
Rabbit Anti-TGF beta Receptor II  antibody (bs-0117R)  
~~~促銷代碼KT202411~~~
訂購熱線:400-901-9800
訂購郵箱:sales@xucheq.com
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@xucheq.com
說明書: 50ul  100ul  200ul
50ul/1180.00元
100ul/1980.00元
200ul/2800.00元
大包裝/詢價(jià)

產(chǎn)品編號(hào) bs-0117R
英文名稱 Rabbit Anti-TGF beta Receptor II  antibody
中文名稱 轉(zhuǎn)移生長因子β受體2抗體
別    名 TGF-beta receptor type-2; TGF beta R2; TGFBR2; AAT 3; AAT3; FAA 3; FAA3; HNPCC6; MFS 2; MFS2; RIIC; TAAD 2; TAAD2; TbetaR II; TGF beta receptor type 2; TGF beta receptor type II; TGF beta type II receptor; TGFB R2; TGFbeta RII; TGFBR 2; TGFR 2; TGFR2; Transforming growth factor beta receptor II; Transforming growth factor beta receptor type II.  TGF-βRⅡ; TGFβRⅡ; TGF βRⅡ; TGFβ RⅡ.
Specific References  (13)     |     bs-0117R has been referenced in 13 publications.
[IF=10.75] Baisheng Li. et al. Decrease of circARID1A retards glioblastoma invasion by modulating miR-370-3p/ TGFBR2 pathway. INT J BIOL SCI. 2022; 18(13): 5123–5135  WB, IHC ;  Mouse, Human.  
[IF=8.702] Xiao, Jiangwei. et al. IRE1α arm of unfolded protein response in muscle-specific TGF-β signaling-mediated regulation of muscle cell immunological properties. CELL MOL BIOL LETT. 2023 Dec;28(1):1-24  WB ;  Mouse.  
[IF=4.869] Xiangrong Chen. et al. ADAM17 Aggravates the Inflammatory Response by Modulating Microglia Polarization Through the TGF-β1/Smad Pathway Following Experimental Traumatic Brain Injury. J NEUROTRAUM. 2023 May 22  IF ;  Rat.  
[IF=4.52] Abdelmagid, Samir M., et al. "Mutation in Osteoactivin Reduces Bone Formation in Vivo and Osteoblast Differentiation in Vitro." The American Journal of Pathology (2014).  WB ;  Rat.  
[IF=4.427] Wu M et al. Synergistic effects of sulfur dioxide and polycyclic aromatic hydrocarbons on pulmonary pro-fibrosis via mir-30c-1-3p/transforming growth factor β type II receptor axis.(2018) Chemosphere 219  WB ;  Mouse&Human.  
[IF=4.292] Longfei Xiao. et al. Dihydrotestosterone through blockade of TGF-β/Smad signaling mediates the anti-fibrosis effect under hypoxia in canine Sertoli cells. J Steroid Biochem. 2022 Feb;216:106041  WB ;  Dog.  
[IF=3.998] Song et al. ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells. (2018) Am.J.Cancer.Res. 8:792-809  WB ;  human.  
[IF=2.71] Hirayama, Hiroki, et al. "Localization of TGF-β and TGF-β receptor in bovine term placentome and expression differences between spontaneous and induced parturition." Placenta (2015).  IHC-P ;  Bovine.  
[IF=2.56] Friedrichs, Jacqueline, et al. "TGF-β1-dependent induction and nuclear translocation of FHL2 promotes keratin expression in pilomatricoma." Virchows Archiv (2014): 1-10.  Human.  
[IF=2.245] Taotao Li. et al. Integrating miRNA and mRNA Profiling to Assess the Potential miRNA–mRNA Modules Linked With Testicular Immune Homeostasis in Sheep. Front Vet Sci. 2021; 8: 647153  WB,IF ;  Sheep.  
[IF=1.858] Zihui Wang. et al. Heat stress and hypoxia inhibit the secretion of androgens and induce epithelial-to-mesenchymal transition associated with activated TGF-β/Smad signaling in canine cryptorchidism. REPROD DOMEST ANIM. 2022 Jun 09  WB ;  Dog.  
[IF=1.564] Liu P et al. Matrine Suppresses Pancreatic Fibrosis by Regulating TGF-β/Smad Signaling in Rats. (2019) Yonsei Med. J. 60(1)  WB ;  Rat.  
[IF=1.5] V?duva IA et al. SMAD4 and TGFβR2 expression in pancreatic ductal carcinoma. Rom J Morphol Embryol. 2019;60(3):803-809.  IHC-P ;  Human.  
研究領(lǐng)域 腫瘤  細(xì)胞生物  神經(jīng)生物學(xué)  信號(hào)轉(zhuǎn)導(dǎo)  生長因子和激素  激酶和磷酸酶  細(xì)胞膜受體  細(xì)胞分化  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human,Mouse,Rat,Cow (predicted: Rabbit,Pig,Sheep,Chicken,Horse)
產(chǎn)品應(yīng)用 IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 62kDa
細(xì)胞定位 細(xì)胞膜 
性    狀 Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human TGF beta Receptor II: 241-330/567 <Cytoplasmic>
亞    型 IgG
純化方法 affinity purified by Protein A
緩 沖 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存條件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事項(xiàng) This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產(chǎn)品介紹 This gene encodes a member of the Ser/Thr protein kinase family and the TGFB receptor subfamily. The encoded protein is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with another receptor protein, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of a subset of genes related to cell proliferation. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized.

Function:
Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.

Subunit:
Homodimer. Heterohexamer; TGFB1, TGFB2 and TGFB3 homodimeric ligands assemble a functional receptor composed of two TGFBR1 and TGFBR2 heterodimers to form a ligand-receptor heterohexamer. The respective affinity of TGFRB1 and TGFRB2 for the ligands may modulate the kinetics of assembly of the receptor and may explain the different biological activities of TGFB1, TGFB2 and TGFB3. Interacts with DAXX. Interacts with TCTEX1D4. Interacts with ZFYVE9; ZFYVE9 recruits SMAD2 and SMAD3 to the TGF-beta receptor.

Subcellular Location:
Cell membrane; Single-pass type I membrane protein.

Post-translational modifications:
Phosphorylated on a Ser/Thr residue in the cytoplasmic domain.

DISEASE:
Defects in TGFBR2 are the cause of hereditary non-polyposis colorectal cancer type 6 (HNPCC6) [MIM:614331]. Mutations in more than one gene locus can be involved alone or in combination in the production of the HNPCC phenotype (also called Lynch syndrome). Most families with clinically recognized HNPCC have mutations in either MLH1 or MSH2 genes. HNPCC is an autosomal, dominantly inherited disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early onset colorectal carcinoma (CRC) and extra-colonic cancers of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world, and accounts for 15% of all colon cancers. Cancers in HNPCC originate within benign neoplastic polyps termed adenomas. Clinically, HNPCC is often divided into two subgroups. Type I: hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II: patients have an increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. HNPCC6 is a type of colorectal cancer complying with the clinical criteria of HNPCC, except that the onset of cancer was beyond 50 years of age in all cases.

Similarity:
Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.
Contains 1 protein kinase domain.

SWISS:
P37173

Gene ID:
7048

Database links:

Entrez Gene: 7048 Human

Entrez Gene: 21813 Mouse

Omim: 190182 Human

SwissProt: P37173 Human

SwissProt: Q62312 Mouse

Unigene: 604277 Human

Unigene: 82028 Human

Unigene: 172346 Mouse



細(xì)胞膜受體(Membrane Receptors)
TGFβR2及家族在進(jìn)化過程中結(jié)構(gòu)和功能高度保守。參與細(xì)胞因子信號(hào)傳導(dǎo),調(diào)節(jié)多種細(xì)胞的生長、分化,在胚胎發(fā)育、組織器官形態(tài)發(fā)生、細(xì)胞的分化、增值及免疫調(diào)節(jié)等方面都起著重要作用。此抗體主要用于散發(fā)性胃癌、結(jié)腸癌及T細(xì)胞淋巴瘤和頭頸部腫瘤方面的研究。
產(chǎn)品圖片
Paraformaldehyde-fixed, paraffin embedded (human breast carcinoma); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Incubation with (TGF beta Receptor II) Polyclonal Antibody, Unconjugated (bs-0117R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (rat spleen); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Incubation with (TGF beta Receptor II) Polyclonal Antibody, Unconjugated (bs-0117R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (human placenta); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Incubation with (TGF beta Receptor II) Polyclonal Antibody, Unconjugated (bs-0117R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (rat placenta); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Incubation with (TGF beta Receptor II) Polyclonal Antibody, Unconjugated (bs-0117R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
Paraformaldehyde-fixed, paraffin embedded (mouse placenta); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Incubation with (TGF beta Receptor II) Polyclonal Antibody, Unconjugated (bs-0117R) at 1:200 overnight at 4°C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.
版權(quán)所有 2004-2026 www.xucheq.com 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號(hào): 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號(hào): CQC24QY10047R0M/1100
京ICP備05066980號(hào)-1         京公網(wǎng)安備110107000727號(hào)
精品人人妻人人澡人人爽牛牛| 好吊妞| 亚洲精品无码永久在线观看你懂的| 免费做爰试看120秒| 国产精品日韩欧美一区二区三区| 亚洲中文字幕无码爆乳AV久久| 亚洲精品国产精品乱码不99| 丰满少妇张开大白腿| 西西里的美丽传说在线观看| 国产内射爽爽大片视频社区在线| 国精无码欧精品亚洲一区| 日本无码小泬粉嫩精品图| 色哟哟网站入口在线观看视频| 亚洲AV永久纯肉无码精品动漫| 国产精品另类激情久久久免费 | 好爽…又高潮了免费毛片| 人妻互换一二三区激情视频| 国产AV无码专区亚洲A∨毛片| 亚洲精品无码久久久久秋霞| 久久久久无码国产精品一区| 蜜臀AV性久久久久蜜臀AⅤ| 国产精品色情国产三级金瓶双艳| 一区二区三区毛A片特级| 国产精品三级在线观看无码| 亚洲精品久久久久久久观小说 | 性色AV蜜臀AV色欲AV| 国产日韩成人内射视频| 337P粉嫩大胆色噜噜噜| 亚洲AV无码久久精品狠狠爱浪潮 | 在线观看电影| 日韩三级| 99久久国产热无码精品免费 | 日本VA欧美VA精品发布| 国产无套内射普通话对白| 人妻AⅤ无码一区二区三区| 北地胭脂| 精品淑女少妇AV久久免费| 少妇一夜三次一区二区| 国产美女极度色诱视频www| 国产自拍AV| 亚洲人成人无码网WWW国产|